Hamm&wittkopp Patentanwälte Partmbb competitive analysis

Explore patent oppositions filed by Hamm&wittkopp Patentanwälte Partmbb against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 10, 2026
Patent NumberTitleApplicantOpposition Date
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZERSep 3, 2026
Combination Comprising An Mek Inhibitor And A B-Raf InhibitorNOVARTISAug 26, 2026
Solid Forms And Formulations Of (S)-4-(8-Amino-3-(1-(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)BenzamideACERTA PHARMAAug 11, 2026
Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla GeneAMICUS THERAPEUTICSAug 3, 2026
Microporous Zirconium Silicate For Treating HyperkalemiaZS PHARMAJun 17, 2026
Pharmaceutical Formulation Comprising EzetimibeASSIA CHEMICAL INDUSTRIESJun 3, 2026
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICSJun 2, 2026
Methods For Treating HyperphenylalaninemiaPTC THERAPEUTICS MPMay 12, 2026
New Oral Pharmaceutical Composition And Dose Regimen For The Therapy Of Progressive Fibrosing Interstitial Lung DiseasesBOEHRINGER INGELHEIMApr 2, 2026
Pharmaceutical FormulationsARRAY BIOPHARMAMar 18, 2026

Latest PTAB cases involving Hamm&wittkopp Patentanwälte Partmbb

Discover the latest PTAB cases involving Hamm&wittkopp Patentanwälte Partmbb, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hamm&wittkopp Patentanwälte Partmbb with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HAMM&WITTKOPP PATENTANWÄLTE PARTMBB82 - - -
AMGEN14163811
JANSSEN PHARMACEUTICA260 - 1
NOVARTIS12542 - 21